Added to YB: 2021-05-08
Pitch date: 2021-05-08
HALO [bullish]
Halozyme Therapeutics, Inc.
+31.97%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
Market Cap
$8.3B
Pitch Price
$47.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
11.07
P/E
14.83
EV/Sales
7.32
Sector
Biotechnology
Category
N/A
Show full summary:
HALOZYME THERAPEUTICS INC HALO
A summary for this pitch has not been created yet.
Read full article (0 min)